전체메뉴 닫기
Запись на приём
Расписание врачей
Запись на приём
Отделения
Найти отделения и специализированные центры

Лист специализированных центров

Отделения

Найти отделения и медицинских персоналов

Сооружения и услуги
Первый визит в больницу
Амбулаторный приём · скорая помощь · госпитализация

Процесс амбулаторный приём

Процесс скорой помощи

Процесс госпитализации/выписки

Расположение и направления
Удобства

B1

1F

2F

3F

Контактная информация
Как найти нас

Карта/ Информация об использовании автомобиля

Информация об использовании общественного транспорта

ЧаВо
Центр послеродового ухода
Медицинская информация
Рубрика о здоровом образе жизни
ЧА СМИ
Здоровая беременность с нуля до конца

We always promise
the best care

Хирургия(центр молочной железы) Prof. Kang, Sung Soo

Расписание Пн Вт Ср Чт Пт Сб
До обеда
После обеда

Специализация

Рак молочной железы

Карьеры профессора

  • Sungkyunkwan University
  • Catholic kwandong University
  • Dankook University
  • CHA University

Медицинский опыт

  • Director of General Surgery, Cheil General Hospital
  • Director of Medical Department and Medical Planning, Cheil General Hospital
  • Director of General Surgery, CHA Ilsan Medical Center, CHA University
  • Breast Center, CHA Ilsan Medical Center, CHA University

Награды

  • Vice president, Korean Breast Cancer Society
  • Head, Directing board, Breast disease department, Korean Surgical Society
  • Research Fellow in Surgery, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, U.S.A
  • Co-author, 4th edition, The breast, Korean Surgical Society

  • Научная статья
  1. Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report. European Journal of Cancer, Volume 151, July 2021, Pages 190-200
  2. Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006). J Breast Cancer. 2021 Apr;24(2):164-174
  3. Factors associated with disease upgrading in patients with papillary breast lesion. in coe-needle biopsy. Gland Surg. 2020;9(4):919-924.
  4. A nationwide, multicenter retrospective study on the effectiveness and safety. of eribulin in Korean breast cancer patients (REMARK). The breast. 2020 Dec. 54:121-126.
  5. Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial. J Clin Oncol, 2020 Feb 10;38(5):434-443.
  6. Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment. J Breast Cancer, 2018 June (공저)
  7. The Usefulness of Intraoperative Circumferential Frozen-Section Analysis of Lumpectomy Margins in Breast-Conserving Surgery.  J Breast Cancer, 2017 June (공저)
  8. Primary osteosarcoma of the breast: a case report. Ann Surg Treat Res. 2017 July (교신저자)
  9. Short-term outcomes of immediate breast reconstruction using an implant or tissue expander after mastectomy in breast cancer patients. Breast Cancer, 2016 Mar. (공저)
  10. The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer, 2016 Mar., (공저)
  11. The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled. BMC Cancer, 2016 May (공저)
  12. The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer, 2016 June (공저)
  13. The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat, 2015 May, (공저)
  14. 유방학(The Breast), 제 1 - 4판. (공저)